TobeyJMacDonaldMD
Pediatric Hematology & Oncology • Atlanta, GAPediatric Neuro-Oncology
Director and Aflac Chair of Pediatric Neuro-Oncology, Aflac Cancer and Blood Disorders Center at Children’s Healthcare of Atlanta and Emory University, Professor of Pediatrics, Emory University School of Medicine
Dr. MacDonald is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2015 Uppergate Drive, 4th floor
Aflac Cancer & Blood Disorders Center
Atlanta, GA 30322Phone+1 404-727-4455Fax+1 404-727-4455- Is this information wrong?
Summary
- Dr. Tobey MacDonald is a pediatric hematologist/oncologist in Atlanta, GA and is affiliated with multiple hospitals in the area, including Children's Healthcare of Atlanta, Emory University Hospital, and Children's Healthcare of Atlanta. He received his medical degree from Weill Cornell Medical College of Cornell University and has been in practice 26 years. He specializes in pediatric neuro-oncology.
Education & Training
Children's Hospital Los AngelesFellowship, Pediatric Hematology/Oncology, 1994 - 1997- Children's Hospital Los AngelesResidency, Pediatrics, 1991 - 1994
Weill Cornell MedicineClass of 1991
Certifications & Licensure
CA State Medical License 1992 - Present
GA State Medical License 2009 - 2025
VA State Medical License 1998 - 2010
DC State Medical License 1998 - 2010
MD State Medical License 1998 - 2009- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Top Doctors- Pediatric Hematology Oncology US News & World Report
Clinical Trials
- Genetic Study of Newly Diagnosed Central Nervous System Tumors in Young Children Start of enrollment: 2001 Mar 01
- Cilengitide in Treating Children With Refractory Primary Brain Tumors Start of enrollment: 2003 Jul 01
- Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG) Start of enrollment: 2011 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3K27M-mutant glioma.Odia, Y., Koschmann, C., Vitanza, N., de Blank, P., Aguilera, D., Allen, J., Daghistani, D., Hall, M., Khatib, Z., Kline, C., MacDonald, T., Mueller, S., Faison, S., A...> ;Neuro-Oncology. 2024 Feb 24
- 2 citationsIndoximod-based chemo-immunotherapy for pediatric brain tumors: A first-in-children phase I trial.Theodore S Johnson, Tobey J MacDonald, Rafal Pacholczyk, Dolly Aguilera, Ahmad Al-Basheer, Manish Bajaj, Pratiti Bandopadhayay, Zuzana Berrong, Eric Bouffet, Robert C ...> ;Neuro-Oncology. 2024 Feb 2
- Visual outcomes after bevacizumab-based therapy for optic pathway glioma.Benjamin I Siegel, Daniel Nelson, Jason H Peragallo, Tobey J MacDonald, David S Wolf> ;Pediatric Blood & Cancer. 2023 Dec 1
- Join now to see all
Journal Articles
- White Matter Network Topology Relates to Cognitive Flexibility and Cumulative Neurological Risk in Adult Survivors of Pediatric Brain TumorsTobey MacDonald, MD, ScienceDirect
Press Mentions
- Georgia State University Researcher Awarded $3 Million to Study Brain Cancer SurvivorsDecember 8th, 2022
- Breaching the Blood-Brain Barrier to Deliver Precious PayloadsMay 7th, 2021
Moleculin Announces Positive Interim Results in Pediatric Brain Tumor Phase 1 Clinical Trial at Emory UniversityOctober 1st, 2020- Join now to see all
Grant Support
- The Role Of Pdgfr In Medulloblastoma ProgressionNational Cancer Institute2010
- The Role Of Pdgfr In Medulloblastoma ProgressionNational Cancer Institute2006–2009
- Phase II Study Of Bevacizumab PLUS Irinotecan (CAMPTORSAR) In Children With RecrNational Center For Research Resources2007–2008
- Pbtc 007 V10b- A Phase I/II Trial Of Zd 1839 (IRESSA)National Center For Research Resources2006–2008
- Pbtc016: A Phase I, Molecular Biology And Phase II Study Of Lapatinib (Gw5720aNational Center For Research Resources2006
- Pbtc-017: Phase I Study Of Cloretazine (VNP40101M) In Children With Recurrent,National Center For Research Resources2006
- Regulation- Medulloblastoma Growth By Alpha-V IntegrinsNational Cancer Institute2002–2006
- Phase I Trial Of SCH 66336 In Ped Patient W/ Refractory Or Recurrent Brain TumorNational Center For Research Resources2005
- Pbtc009 - Phase I Trial Of Gliadel And O6-BenzylguanineNational Center For Research Resources2005
- Pbtc-012: Phase I Study Of Cilengiude (Emd 121974) In Child W Brain TumorsNational Center For Research Resources2005
- Pbtc-006: A Phase I/II Trial Of STI571 In ChildrenNational Center For Research Resources2005
- Pbtc 005 - Phase I Trial Of Temozolomide &06 Benzylguanine In Pediatric PatientNational Center For Research Resources2005
- Pbtc 007 V1.0b- A Phase I/II Trial Of Zd 1839 (IRESSA)National Center For Research Resources2004
- Pbtc 005v1.1 Phase I Trial Of Temozolomide And O6-BenzylguanineNational Center For Research Resources2004
- Pbtc 003-A Phase I Trial Of Escalating Oral Dose Of SCH66336 In PediatricNational Center For Research Resources2004
- A Phase I Study Of Cilengitide (Emd 121974) In Pediatric Patients With RefractorNational Center For Research Resources2004
Professional Memberships
- Member
Hospital Affiliations
Children's Healthcare of AtlantaAtlanta, Georgia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
